Ayucare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.20 M
as on 06-12-2024
- Revenue %
(FY 2021)
- Profit 411.20%
(FY 2021)
- Ebitda 2405.96%
(FY 2021)
- Net Worth 43.77%
(FY 2021)
- Total Assets 401.32%
(FY 2021)
About Ayucare Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.20 M.
Jay Acharya, Meet Acharya, Madhu Acharya, and One other member serve as directors at the Company.
- CIN/LLPIN
U30009GJ1995PTC026563
- Company No.
026563
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationAhmedabad, Gujarat
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ayucare Pharmaceuticals Pvt Ltd offer?
Ayucare Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Digestive System Drugs & Medicines, Digestive Drugs, Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement, Ayurvedic Herbal Syrups & Tonics, Cosmetics, Hair & Beauty Products, Hair Care Products, Herbal Oil.
Who are the key members and board of directors at Ayucare Pharmaceuticals?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jay Acharya | Director | 30-Jun-1995 | Current |
Meet Acharya | Director | 13-Dec-2019 | Current |
Madhu Acharya | Director | 29-Feb-2020 | Current |
Urvashi Acharya | Director | 13-Dec-2019 | Current |
Financial Performance of Ayucare Pharmaceuticals.
Ayucare Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 411.2% increase in profit. The company's net worth Soared by an impressive increase of 43.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ayucare Pharmaceuticals?
In 2019, Ayucare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Union Bank Of India Creation Date: 21 Feb 2004 | ₹0.10 M | Open |
Union Bank Of India Creation Date: 21 Feb 1998 | ₹0.10 M | Open |
How Many Employees Work at Ayucare Pharmaceuticals?
Unlock and access historical data on people associated with Ayucare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayucare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayucare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.